Amgen stock slouched Wednesday after a Lilly exec called the company's early-stage test results for a weight-loss drug "a bit underwhelming."
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Amgen’s Weight-Loss Results Are ‘A Bit Underwhelming,’ Says Lilly Executive